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This study is based on the evaluation of acid neutralizing capacity of five different commercial brands of antacid 
tablets. Five different but widely used commercial antacid tablets were selected for the purpose of this study. 
Each of the sample tablets was purchased, crushed, weighed and kept at room temperature before being 
analyzed using titrimetric method. Titration of each sample tablet (0.5 g) dissolved in 20 cm
3
 of 0.1 M HCl with 
0.1 M NaOH was carried out and the average titer values of different runs were recorded. The titre value for 




 for Gestid, 10.02 cm
3
 for Danacid, 10.10 cm
3 
for Cimetidine and 10.05 cm
3
 
for Rennietidine. The neutralizing capacity (NC) of Gaviscon was found to be 82.6%, 53.4% for Gestid, 64.8% 
for Danacid, 49.8%
 
for Cimetidine and 36.6% for Rennietidine. Analysis of the results shows that Gaviscon 
tablet has the highest NC, while Rennietidine shows lower NC value. 
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INTRODUCTION 
Antacid is any substance, generally a base 
or basic salt, which neutralizes stomach acidity. 
Antacids are pharmaceutical drugs being basic in 
nature and having a characteristic ability to 
neutralize an acid of the gastric content (such as 
stomarch) and thus lower the acidity of the content 
(van Riet-Nales et al., 2002). Antacid works on the 
basis of different mechanism including directly 
neutralising acidity, increasing the pH or reversibly 
reducing or blocking the secretion of acid by the 
gastric cell to reduce acidity in the stomach (Pali, 
et al., 2011). They are generally used to relieve 
acid indigestion, stomach upset, sour stomach and 
heartburn. Antacids also prevent irritation of the 
stomach ulcer and help relieve any pain which is 
associated with such ulcer. In addition antacid are 
known to reduce peptic activity by acting as 
pepsins.  All antacids contain bases with a net pH 
above 7 and have a buffer (substances that help 
minimize changes in the concentrations of 
hydrogen (H
+
) and hydroxyl (OH
-
) ions). Changing 
of the gastric content to pH 4.0 and 4.2, antacids 
prevent irritation of the ulcer and relieve pain (van 
Riet-Nales et al., 2002). They also reduce peptic 
activity as pepsin is inactive at this pH 4.0 and 
above. However, they do not affect the rate of 
healing of peptic ulcer but are used to relieve ulcer 
pain and encourage healing (Farzaei et al., 2013). It 
is also reported that antacids promote the healing in 
duodenal ulcer (Zajac et al., 2013). Different 
brands of antacids are now available for the relieve 
of heartburn and peptic ulcer pain. Commercial 
antacid comes in two forms, either as liquids or as 
solid tablets. The principal constituents of antacids 
are magnesium and aluminum as hydroxides alone 
or in combination (Smith et al., 1976). Some 
contains salt of calcium, sodium, carbon or 
bismuth. The effectiveness of each antacid depends 
on its neutralizing capacity and the transit time in 
the stomach. Liquid preparations of antacids are 
more effective than the solid ones (tablets) because 
the constituents are already in their form (Duffy et 
al., 1982).  
This research work is aimed at evaluating 
the acid neutralizing capacity of five different 
commercial brands of antacid tablets using 
titrimetric method of analysis.  
 
MATERIALS AND METHODS 
Pharmaceutical drugs used 
The five different brands of commercial 
antacids tablet used in this research work were 
purchased in Damaturu at Gidantu Patient medicine 
store, along Maiduguri road opposite Government 
House Damaturu, Yobe state. These are Danacid, 
Cimetidine, Gaviscon, Gestid and Rennietidine all 
in form of tablets.  
 
PREPARATION OF SAMPLES AND 
REAGENTS 
0.1 M Hydrochloric Acid Solution  
0.1 M HCl was prepared by diluting 8.6 
cm
3 
of 12 M HCl with deionized water in 1litre 
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volumetric flask. After the addition of the acid the 
volume of the flask was made to the mark using 
deionised water. 
 
0.1M Sodium Hydroxide Solution 
0.1 M NaOH was prepared by dissolving 
4.0 g of NaOH with deionized water in 1litre 
volumetric flask. After the dissolution process, the 
volume was made to the mark. 
 
0.1 M Potassium Hydrogen Phthalate (KHP) 
Solution 
2.04 g of KHP was weighed and properly 
dissolved with deionized water in 100 cm
3
 
volumetric flask. After the dissolution process, the 
volume was made to the mark with the deionized 
water. 
 
Standardization of Sodium Hydroxide Solution 
20 cm
3
 of 0.1 M KHP was measured into a 
250 cm
3
 Erlenmeyer flask followed by the addition 
of 3 drops of phenolphthalein indicator. The 
solution was titrated with 0.1 M sodium hydroxide 
solution until it turns pink which persisted for at 
least 30 seconds. The volume of 0.1 M NaOH 
solution used was recorded. The titration procedure 
was repeated 3 more times, and the average titre 
value was recorded. 
 
Standardization of Hydrochloric Acid Solution  
20 cm
3
 of the 0.1 M HCl solution was 
measured into a 250 cm
3
 Erlenmeyer flask 
followed by the addition of 3 drops of 
phenolphthalein indicator. The solution was then 
titrated with 0.1 M NaOH until the solution turns 
pink which persisted for 30 seconds without fading. 
The titration procedure was repeated 3 times, and 
the average titre value was recorded. 
 
Evaluation of the Neutralizing Capacity of 
Antacids Tablets 
Sample of each antacids tablet was 
separately weighed and crushed using a mortar and 
pestle. 0.5 g of the crushed tablet was weight and 
transferred into a 250 cm
3
 Erlenmeyer flask. This is 
followed by the addition       20 cm
3
 of the 
standardized HCl solution and swirled gently to 
dissolve the crush tablet as completely as possible. 
3 drops of bromophenol blue indicator were added 
to the solution which then turns yellow (if the 
solution is still blue, then additional  10 cm
3
 of HCl 
is required until the solution is yellow). The 
solution was titrated with the standardized NaOH 
until it turns blue (van Dop, et al., 1976 and Lin, et 
al., 1998). The titration procedure was repeated 3 
times, and the average titre value was recorded.  
The same procedure was repeated on all 
the other brands of antacid tablets and the average 
titre value of the NaOH solution required to 
neutralize the excess acid (HCl) for each brand of 
the antacid was recorded.  
 
RESULTS AND DISCUSSION 
Analysis of Antacid Tablets 
Analysis of the different commercial brand of 
antacids tablet was carried out to evaluate their acid 
neutralizing capacity and results was given in Table 
1. 
 
TABLE 1: Results of antacid tablets analysis 
 Danacid Cimetidine Gaviscon Gestid Rennietidine 
Titre value (cm
3
) 10.02 10.10 9.20 13.04 10.05 




2.0 2.0 2.0 2.0 2.0 




1.002 1.010 0.920 1.304 1.005 




9.98 9.90 10.80 6.96 9.95 
Mass of Antacid used (g) 0.5 0.5 0.5 0.5 0.5 
Molar mass of the antacid (g/mol) 325 252 382 383 184 
Excess HCl neutralized by a molar 
mass unit of Antacid (g/mol) 
0.324 0.249 0.413 0.267 0.183 
NC or % of Excess HCl neutralized  64.8 49.8 82.6 53.4 36.6 
 
According to the results obtained in the 
analysis of different brands of antacid tablets 
(Table 1), it was clear that Gaviscon tablet shows 
lower average titer value of 9.20 cm
3
, while Gestid 
tablet has the highest average titer value of 13.04 
cm
3
. This indicate that Gaviscon with the lower 
average titre value records the highest value of the 
excess HCl neutralized, while Gestid with the 
highest titre value records the lowest value of the 
excess HCl neutralized. This means more amount 
Gestid is needed to neutralize same amount of HCl 
compared to other antacids used in the study. 
Similarly, less amount of Gaviscon is needed to 
neutralize same amount of HCl compared to the 
rest of the antacids used in the study.  
The total amount of HCl (mole) used was 
determined using the equation (1), while the 
amount of HCl (mole) neutralized by NaOH was 
determined using the expression (2). The amount of 
excess HCl neutralized by antacid was determined 
by subtracting the amount of HCl neutralized by 
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NaOH from the total amount of HCl used as represented by equation (3), (Heriro, et al., 1997).
 
                               
                              




                                 
                                  
       
 ….(2) 
 
Excess HCl neutralized by antacid = M (HCl ) – M (HCl neutralized by NaOH) ……… (3)  
The moles of excess HCl neutralized was 
multiplied by the molar mass of the antacid and in 
order to get the moles of excess HCl per molar 
mass unit of the antacid.  
Each antacid tablet has different active ingredient, 
so for Gavison contains NaHCO3, CaCO3 and 
NaC6H7O6; Gestid has Mg2O8Si3, Al(OH)3 and 
Mg(OH)2; Danacid has Mg2O8Si3 and Al(OH)3; 
Rennietidine has CaCO3 and MgCO3; while 
Cimetidine has C10H16N6S. 
Percentage of the excess HCl neutralized or the 
neutralizing capacity was calculated for each brand 
of antacids as follows;  
 
                                
                                                             
                
       
 
Therefore, it was clear from the results 
that Gaviscon gives the highest neutralizing 
capacity of 82.6% while, Rennietidine represent the 
tablet with lowest neutralizing capacity of 36.6%.  
 
CONCLUSION  
From the results shown it was clear that 
Gaviscon tablet is more active, because it 
neutralized more amount of acid than the rest. It is 
recommended that further work should be carried 
out on other antacid drugs particularly on the 
enzymatic assay, cytotoxicity and tissue absorption 
to fully ascertain their neutralizing capacity.  
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